A rational explanation of the vancomycin release from SBA-15 and its derivative by molecular modelling
- 31 August 2010
- journal article
- Published by Elsevier BV in Microporous and Mesoporous Materials
- Vol. 132 (3), 559-566
- https://doi.org/10.1016/j.micromeso.2010.04.010
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Contribution of vraSR and graSR Point Mutations to Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2009
- Opportunities for nanotechnology-enabled bioactive bone implantsJournal of Materials Chemistry, 2009
- In Vitro and In Vivo Bactericidal Activities of Vancomycin Dispersed in Porous Biodegradable Poly(ε-Caprolactone) MicroparticlesAntimicrobial Agents and Chemotherapy, 2005
- Antibiotic susceptibility of bacteria most commonly isolated from bone related infections: the role of cephalosporins in antimicrobial therapyInternational Journal of Antimicrobial Agents, 2004
- Pyridine-15N A Mobile NMR Sensor for Surface Acidity and Surface Defects of Mesoporous SilicaThe Journal of Physical Chemistry B, 2003
- Silica sol-gel for the controlled release of antibiotics. II. The effect of synthesis parameters on thein vitro release kinetics of vancomycinJournal of Biomedical Materials Research, 2001
- A self-setting TTCP-DCPD apatite cement for release of vancomycinJournal of Biomedical Materials Research, 1996
- Molecular basis of the activity of antibiotics of the vancomycin groupPure and Applied Chemistry, 1989
- Hydrophobic interactions affect hydrogen bond strengths in complexes between peptides and vancomycin or ristocetinJBIC Journal of Biological Inorganic Chemistry, 1984
- Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matricesJournal of Pharmaceutical Sciences, 1963